Your search for View All Case Studies returned 26 results.

Sort the Following Results By:

"Community" Service
The firm served as lead counsel for Gables Residential in the disposition of a portfolio of 35+ multi-family properties in six metropolitan areas more
Chipped Away
What started as a single patent infringement action in the United States District Court for the Western District of North Carolina, and morphed into more Chipped Away
Breakthrough
The United States Patent and Trademark Office (USPTO) has expanded from a single location to have satellite patent offices in Denver and Detroit,

 more Breakthrough
Bet the Farm
Kilpatrick Townsend represented a leading livestock producer in Illinois. Our clients were sued in Illinois Circuit Court by 21 nearby residents -- more Bet the Farm
Unambiguous Win
Significant patenting and patent portfolio management activities continue to be a critical, albeit less visible, cornerstone of Kilpatrick Townsend’s

 more Unambiguous Win
Against the Current
Kilpatrick Townsend’s Native American team successfully represented Frank’s Landing Indian Community (Frank’s Landing), a thriving

 more Against the Current

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Representing investment manager in structuring investment vehicles
Representing and advising a $1 billion investment manager in structuring privately-offered domestic and offshore investment vehicles. more
Mutual to stock conversion and IPO of American Financial Holdings Inc.
Represented American Savings Bank in its mutual-to-stock conversion and the related $267.3 million initial public offering by its newly formed more
Construction arbitration for Florida construction company
Represented a Florida construction company, specializing in contracting and construction management services, in disputes arising from the more
Antitrust review of merger between pharmaceutical companies
Represented a pharmaceutical company before FTC regarding antitrust review of merger with another pharmaceutical company and negotiation of consent more